Detailed Information

Cited 14 time in webofscience Cited 15 time in scopus
Metadata Downloads

Apoptotic cell death of human leukaemia U937 cells by ubiquinone-9 purified from Pleurotus eryngii

Full metadata record
DC Field Value Language
dc.contributor.authorBae, Jeen-Soo-
dc.contributor.authorPark, Jin Wook-
dc.contributor.authorPark, So Hyun-
dc.contributor.authorPark, Jung Bin-
dc.contributor.authorRho, Yoon-Hwa-
dc.contributor.authorRyu, Young Bae-
dc.contributor.authorLee, Kun-Sik-
dc.contributor.authorPark, Ki-Hun-
dc.contributor.authorBae, Young-Seuk-
dc.date.accessioned2022-12-27T05:54:28Z-
dc.date.available2022-12-27T05:54:28Z-
dc.date.issued2009-
dc.identifier.issn1478-6419-
dc.identifier.issn1478-6427-
dc.identifier.urihttps://scholarworks.gnu.ac.kr/handle/sw.gnu/27156-
dc.description.abstractA chloroform extract of the edible mushroom Pleurotus eryngii showed an inhibitory effect on mammalian DNA topoisomerase I. The topoisomerase I inhibitory compound was purified and identified as ubiquinone-9. Ubiquinone-9 was shown to inhibit the activity of topoisomerase I with IC50 of about 50 mu M. Concentration of 110 mu M ubiquinone-9 caused 50% growth inhibition of human leukaemia U937 cells, but not that of normal fibroblast NIH3T3 and 3Y1 cells. Ubiquinone-9-induced cell death was characterised with the cleavage of poly (ADP-ribose) polymerase and pro-caspase 3. Furthermore, ubiquinone-9 induced the fragmentation of DNA into an apoptotic DNA ladder, indicating that the inhibitor triggered apoptosis. The induction of apoptosis by ubiquinone-9 was also confirmed using flow cytometry analysis. Taken together, these results suggest that ubiquinone-9 may function by inhibiting oncogenic disease, at least in part, through the inhibition of topoisomerase I activity.-
dc.format.extent8-
dc.language영어-
dc.language.isoENG-
dc.publisherTAYLOR & FRANCIS LTD-
dc.titleApoptotic cell death of human leukaemia U937 cells by ubiquinone-9 purified from Pleurotus eryngii-
dc.typeArticle-
dc.publisher.location영국-
dc.identifier.doi10.1080/14786410802417107-
dc.identifier.scopusid2-s2.0-70349511965-
dc.identifier.wosid000268758600007-
dc.identifier.bibliographicCitationNATURAL PRODUCT RESEARCH, v.23, no.12, pp 1112 - 1119-
dc.citation.titleNATURAL PRODUCT RESEARCH-
dc.citation.volume23-
dc.citation.number12-
dc.citation.startPage1112-
dc.citation.endPage1119-
dc.type.docTypeArticle-
dc.description.isOpenAccessN-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.relation.journalResearchAreaChemistry-
dc.relation.journalResearchAreaPharmacology & Pharmacy-
dc.relation.journalWebOfScienceCategoryChemistry, Applied-
dc.relation.journalWebOfScienceCategoryChemistry, Medicinal-
dc.subject.keywordPlusDNA TOPOISOMERASE-I-
dc.subject.keywordPlusCAMPTOTHECIN-
dc.subject.keywordPlusINHIBITOR-
dc.subject.keywordPlusCLEAVAGE-
dc.subject.keywordAuthorPleurotus eryngii-
dc.subject.keywordAuthorubiquinone-9-
dc.subject.keywordAuthorDNA topoisomerase I inhibitor-
dc.subject.keywordAuthorapoptosis-
dc.subject.keywordAuthorhuman leukaemia cells-
dc.subject.keywordAuthoranticancer drug-
Files in This Item
There are no files associated with this item.
Appears in
Collections
ETC > Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Altmetrics

Total Views & Downloads

BROWSE